Sustainable Pharma Packaging Market Set to Reach $270 Billion by 2031

The global market for sustainable pharmaceutical packaging is projected to surge to $270.4 billion by 2031, up from $114.5 billion in 2025. Driven by strict environmental regulations and corporate ESG mandates, the sector is currently undergoing a structural shift toward recyclable, bio-based, and lightweight material solutions.

Pharmaceutical manufacturers are increasingly prioritizing carbon footprint reduction, pushing the industry toward a 15.4% compound annual growth rate. According to Mayur Jain, a research expert at Wissen Research, the transition is fueled by advancements in material science that allow for the use of mono-materials and bio-polymers without compromising product sterility or regulatory compliance.

Strategic consolidation is defining the current landscape, exemplified by the recent merger of Amcor plc and Berry Global Group, as well as feasibility studies between Becton, Dickinson and Company and Envetec Sustainable Technologies. These collaborations focus on establishing closed-loop recycling systems for medical plastics. Despite this momentum, the industry faces significant hurdles, including the high cost of eco-friendly alternatives and the technical complexity of ensuring barrier performance in recycled materials. North America remains the dominant market, while the Asia-Pacific region is expected to see the fastest growth due to rising pharmaceutical production and government-led sustainability initiatives.